Adult woman
Conditions
Interventions
None listed
Sponsors
TechDoctor, Inc.
ASKA Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1)Premenopausal women between the ages of 18 and 49 at the time consent is obtained (2)Those whose menstrual cycles can be confirmed (3)Those who regularly record menstrual information in a health care application (4)Own a smartphone device on which the wearable device application can be installed, and agree to the terms of use for the wearable device and application used in the study. (5)Those who have given appropriate written consent to participate in this study.
Exclusion criteria
Exclusion criteria: (1)Who have an infectious disease or a disease under treatment that makes it difficult for them to manage their health (2)Patients who have been taking estrogen/progestin, progestin, or GnRH analogs within 2 months of the start of the study (3)Who have not had a menstrual period for more than 3 months, are pregnant, or are lactating (4)Who are using devices or medications that can affect the heartbeat, such as pacemakers or drugs (5)Those with eczema, allergies, asthma, sensitive skin, or other conditions that could easily cause dermatitis due to wearable devices (6)Any other person who is deemed by the principal investigator to be inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Explore wearable device data in relation to MDQ scores | — |
Secondary
| Measure | Time frame |
|---|---|
| (1)Explore wearable device data associated with QOL questionnaire scores (2)Relationship between physical condition records and MDQ scores in apps | — |
Countries
Japan
Contacts
Public ContactKosaku Kawada
TechDoctor, Inc. Business Development
Outcome results
None listed